Observational study / 2018
Elevated admission TMAO was linked to all-cause mortality in COPD patients, but the link was no longer significant after multivariate adjustment.
A total of 189 patients with COPD exacerbation were prospectively followed for a median of 6.1 years. All-cause mortality was 55.6% after 6 years, with deceased patients showing higher median admission TMAO levels than survivors (3.9 vs. 2.9 μmol/L; P = 0.01), giving an unadjusted hazard ratio of 1.8 (95% CI: 1.2-3.0, P = 0.01). However, this association was no longer significant after multivariate adjustment, as it was largely explained by comorbidities and age.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 189 patients with COPD exacerbation followed for a median of 6.1 years
- What was measured
- Associations of TMAO with all-cause mortality and comorbidities
THE PAPER
Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
Ottiger M, Nickler M, Steuer C, Bernasconi L, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Mueller B, Schuetz P. Nutrition, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.